Maternal and fetal outcomes following elexacaf tor-tezacaf tor-ivacaf tor use during pregnancy and lactation

Taylor-Cousar, JL; Jain, R

Taylor-Cousar, JL (corresponding author), Natl Jewish Hlth, Dept Med & Pediat, 1400 Jackson St,J318, Denver, CO 80206 USA.

JOURNAL OF CYSTIC FIBROSIS, 2021; 20 (3): 402

Abstract

Background: With the improved health afforded by cystic fibrosis transmembrane conductance regulator (CFTR) modulators, pregnancy rates are increasing......

Full Text Link